Vireo Growth Inc. (VREOF) stock
VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/30
$9.01+0.01 (+0.11%)
Close on Oct 19, 2026Market cap $406.23MP/E –Yield –
Vireo Growth revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Vireo Growth's revenue for the twelve months ending Jun 30, 2026 was $511.67M, up 316.7% year over year. For fiscal 2025 it was $268.77M, up 170.4% from the year before. The highest annual figure on record is $268.77M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $268.77M | +170.4% |
| FY2024 | Dec 31, 2024 | $99.38M | +12.8% |
| FY2023 | Dec 31, 2023 | $88.13M | +18.1% |
| FY2022 | Dec 31, 2022 | $74.63M | +37.1% |
| FY2021 | Dec 31, 2021 | $54.45M | +10.6% |
| FY2020 | Dec 31, 2020 | $49.21M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $209.30M | +335.1% |
| Q1 FY2026 | Mar 31, 2026 | $106.20M | +333.5% |
| Q4 FY2025 | Dec 31, 2025 | $104.51M | +317.7% |
| Q3 FY2025 | Sep 30, 2025 | $91.66M | +264.2% |
| Q2 FY2025 | Jun 30, 2025 | $48.10M | +91.6% |
| Q1 FY2025 | Mar 31, 2025 | $24.50M | +1.7% |
| Q4 FY2024 | Dec 31, 2024 | $25.02M | +3.5% |
| Q3 FY2024 | Sep 30, 2024 | $25.17M | +2.0% |
| Q2 FY2024 | Jun 30, 2024 | $25.11M | +24.3% |
| Q1 FY2024 | Mar 31, 2024 | $24.09M | +26.2% |
| Q4 FY2023 | Dec 31, 2023 | $24.17M | +26.9% |
| Q3 FY2023 | Sep 30, 2023 | $24.68M | +30.9% |
| Q2 FY2023 | Jun 30, 2023 | $20.20M | -4.2% |
| Q1 FY2023 | Mar 31, 2023 | $19.09M | +22.1% |
| Q4 FY2022 | Dec 31, 2022 | $19.04M | +39.4% |
| Q3 FY2022 | Sep 30, 2022 | $18.85M | +41.0% |
| Q2 FY2022 | Jun 30, 2022 | $21.09M | +48.2% |
| Q1 FY2022 | Mar 31, 2022 | $15.64M | +18.6% |
| Q4 FY2021 | Dec 31, 2021 | $13.66M | +10.1% |
| Q3 FY2021 | Sep 30, 2021 | $13.37M | +7.2% |
| Q2 FY2021 | Jun 30, 2021 | $14.23M | +16.5% |
| Q1 FY2021 | Mar 31, 2021 | $13.19M | +8.8% |
| Q4 FY2020 | Dec 31, 2020 | $12.40M | – |
| Q3 FY2020 | Sep 30, 2020 | $12.48M | – |
| Q2 FY2020 | Jun 30, 2020 | $12.22M | – |
| Q1 FY2020 | Mar 31, 2020 | $12.12M | – |
See a number that looks wrong?